Novavax, Inc., today announced its financial results for the fourth quarter and twelve months ended December 31, 2016. Continued execution of the global Phase 3 PrepareTM clinical trial to prevent RSV in infants via maternal immunization.
Category: Bill and Melinda Gates Foundation
New Grant Boosts UC San Diego-Led Malaria Research Program
An international research team, led by principal investigator Elizabeth A. Winzeler, PhD, professor in the pediatric division of host-microbe systems and therapeutics at University of California San Diego School of Medicine, and colleagues have received a three-year, $4.7 million supplemental grant from the Bill & Melinda Gates Foundation to advance their development of improved therapies for malaria eradication and elimination.
East/West CEO Conference to Feature Prominent CEOs and Industry Leaders on January 7th & 8th
Join Deborah Dunsire,CEO, Southern Cross Biotech Consulting;Tom Heyman,CEO, Janssen Pharmaceutica;Charlotte Hubbert,Partner, Bill & Melinda Gates Foundation;Emil Kakkis,CEO & President, Ultragenyx;Mathai Mammen,SVP Research, Merck;Geoff McDonough,President & CEO, Sobi;Susan Molineaux,President & CEO, Calithera;Paris Panayiotopoulos,President & CEO, ARIAD;Rob Perez,Founder and Chairman, Life Science Cares;David Pyott,Former CEO, Allergan;Paul Stoffels,CSO, Johnson & Johnson;Henri Termeer, former CEO,Genzyme;J.